Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE: 300832)

Market Cap	48.64B
Revenue (ttm)	4.44B
Net Income (ttm)	1.85B
Shares Out	785.72M
EPS (ttm)	2.36
PE Ratio	26.28
Forward PE	22.10
Dividend	1.00 (1.62%)
Ex-Dividend Date	May 15, 2024

Volume	2,698,423
Average Volume	3,577,488
Open	63.31
Previous Close	62.76
Day's Range	61.64 - 63.35
52-Week Range	58.31 - 97.20
Beta	-0.41
RSI	41.24
Earnings Date	Apr 18, 2025

About Shenzhen New Industries Biomedical Engineering

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,627
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2023, Shenzhen New Industries Biomedical Engineering's revenue was 3.93 billion, an increase of 28.97% compared to the previous year's 3.05 billion. Earnings were 1.65 billion, an increase of 24.53%.